Amphastar Pharmaceuticals (FRA:29A) Operating Cash Flow per Share : €3.47 (TTM As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Amphastar Pharmaceuticals Operating Cash Flow per Share?

Amphastar Pharmaceuticals's operating cash flow per share for the three months ended in Mar. 2025 was €0.65. Amphastar Pharmaceuticals's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was €3.47.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Amphastar Pharmaceuticals was 0.90% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 27.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 37.20% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 26.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Amphastar Pharmaceuticals's Operating Cash Flow per Share or its related term are showing as below:

FRA:29A' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -40.6 Med: 22 Max: 51.2
Current: 27.7

During the past 13 years, Amphastar Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 51.20% per year. The lowest was -40.60% per year. And the median was 22.00% per year.

FRA:29A's 3-Year OCF Growth Rate is ranked better than
71.41% of 780 companies
in the Drug Manufacturers industry
Industry Median: 8.85 vs FRA:29A: 27.70

Amphastar Pharmaceuticals Operating Cash Flow per Share Historical Data

The historical data trend for Amphastar Pharmaceuticals's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amphastar Pharmaceuticals Operating Cash Flow per Share Chart

Amphastar Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.96

1.74

1.61

3.18

3.92

Amphastar Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.96	1.23	1.04	0.54	0.65

Competitive Comparison of Amphastar Pharmaceuticals's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Amphastar Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amphastar Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amphastar Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Amphastar Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Amphastar Pharmaceuticals Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Amphastar Pharmaceuticals's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	203.784	/	52.058
	=	3.91

Amphastar Pharmaceuticals's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )	=	Cash Flow from Operations (Q: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
	=	32.446	/	49.890
	=	0.65

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.47

Amphastar Pharmaceuticals Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Amphastar Pharmaceuticals's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Amphastar Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amphastar Pharmaceuticals Inc (FRA:29A) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

AMPH:USA

Address

11570 6th Street, Rancho Cucamonga, CA, USA, 91730

Website

https://www.amphastar.com

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Amphastar Pharmaceuticals Headlines

No Headlines